ALPS ETF TR - MED BREAKTHGH (SBIO)

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,755,390
Share change
+429,693
Total reported value
$65,400,864
Put/Call ratio
41%
Price per share
$37.27
Number of holders
44
Value change
+$16,203,724
Number of buys
28
Number of sells
12

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2018

As of 30 Jun 2018, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,755,390 shares. The largest 10 holders included BANK OF AMERICA CORP /DE/, UBS Group AG, BAROMETER CAPITAL MANAGEMENT INC., MORGAN STANLEY, WELLS FARGO & COMPANY/MN, RAYMOND JAMES & ASSOCIATES, NTV Asset Management LLC, LPL Financial LLC, CITADEL ADVISORS LLC, and ROYAL BANK OF CANADA. This page lists 45 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.